An evaluation of 2 new devices for nasal high-flow gas therapy.
BACKGROUND
The traditional nasal cannula with bubble humidifier is limited to a maximum flow of 6 L/min to minimize the risk of complications. We conducted a bench study of 2 new Food and Drug Administration-approved nasal cannula/humidifier products designed to deliver at flows> 6 L/min.


METHODS
Using a digital psychrometer we measured the relative humidity and temperature of delivered gas from each device, at 5 L/min increments over the specified functional high-flow range.


RESULTS
The Salter Labs unit achieved 72.5-78.7% relative humidity (5-15 L/min range) at ambient temperature (21-23 degrees C). The Vapotherm device achieved 99.9% relative humidity at a temperature setting of 37 degrees C (5-40 L/min).


CONCLUSIONS
Both devices meet minimum humidification standards and offer practical new treatment options. The patient-selection criteria are primarily the severity of the patient's condition and cost.
Waugh
Jonathan B
JB
Respiratory Therapy Program, Critical Care Sciences Department, University of Alabama at Birmingham, 1705 University Blvd, RMSB 480, Birmingham AL 35294-1212, USA. waughj@gmail.com.
Granger
Wesley M
WM
D019985:Benchmarking; D004867:Equipment Design; D006358:Hot Temperature / Q000627:therapeutic use; D006801:Humans; D006813:Humidity; D009330:Nebulizers and Vaporizers; D010102:Oxygen Inhalation Therapy / Q000295:instrumentation*; D013696:Temperature